APA (7th ed.) Citation

Seckinger, A., Salwender, H., Martin, H., Scheid, C., Hielscher, T., Bertsch, U., . . . Hose, D. (2018). Treatment response and long-term survival in multiple myeloma in the GMMG-HD4 trial: Neither profit all molecular entities alike, nor are remissions to different regimen equal. Blood, 132, . https://doi.org/10.1182/blood-2018-99-113284

Chicago Style (17th ed.) Citation

Seckinger, Anja, et al. "Treatment Response and Long-term Survival in Multiple Myeloma in the GMMG-HD4 Trial: Neither Profit All Molecular Entities Alike, nor Are Remissions to Different Regimen Equal." Blood 132 (2018). https://doi.org/10.1182/blood-2018-99-113284.

MLA (9th ed.) Citation

Seckinger, Anja, et al. "Treatment Response and Long-term Survival in Multiple Myeloma in the GMMG-HD4 Trial: Neither Profit All Molecular Entities Alike, nor Are Remissions to Different Regimen Equal." Blood, vol. 132, 2018, https://doi.org/10.1182/blood-2018-99-113284.